Oznámenie o prerušení, obnovení alebo zrušení dodávok humánneho lieku
 PodanieDržiteľKódLiekÚčinnosť ▲Predmet
 14.7.2022Actavis Group PTC ehf. (ACT-5)31908Desloratadine Actavis 5 mg filmom obalené tablety (tbl flm 50x5 mg (blis.OPA/Al/PVC/Al))10.9.2022R
 8.7.2022Genzyme Europe B.V. (GZE-1)32669Caprelsa 300 mg filmom obalené tablety (tbl flm 30x300 mg (blis.PVC/PVDC/Al))2.9.2022R
 1.6.2021UCB s.r.o. (UCB-CZ-2)32720Xyzal (tbl flm 50x5 mg (blis.Al/OPA/Al/PVC))1.9.2022R
 28.7.2022Merck Sharp & Dohme B.V. (MSD-NL)95505VARIVAX (plv iul 1x3 ml inj.l.s pr.(min.1350 PFU/ 0,5 ml)+1x1 ml nap.i.s.+2 ihly)1.9.2022R
 22.7.2022Teva B.V. (TEV-NL-4)4968BBrieka 300 mg (cps dur 56x300 mg (blis.Al/PVC))1.9.2022R
 2.8.2022Actavis Group PTC ehf. (ACT-5)4648AActelsar HCT 80 mg/25 mg tablety (tbl 28x80 mg/25 mg (blis.Al/Al))31.8.2022R
 21.7.2022Adamed Pharma S.A. (AFD)9322CADAXIB 100 mg (cps dur 30x100 mg (blis.PVC/PVDC/Al))31.8.2022Z
 2.5.2022Janssen - Cilag International N.V. (JNS)40531VELCADE 3,5 mg prášok na injekčný roztok (plv ino 1x3,5 mg (liek.inj.skl.))31.8.2022Z
 21.7.2022Adamed Pharma S.A. (AFD)9326CADAXIB 200 mg (cps dur 30x200 mg (blis.PVC/PVDC/Al))31.8.2022Z
 23.6.2022Mylan Ireland Limited (MNY)4723CErlotinib Mylan 100 mg (tbl flm 30x100 mg (blis.Al/OPA/Al/PVC))31.8.2022Z
 31.7.2022ratiopharm GmbH (RAT)37698Moxonidin-ratiopharm 0,2 mg (tbl flm 100x0,2 mg (blis.PVC/PVDC/Al))30.8.2022R
 14.7.2022Actavis Group PTC ehf. (ACT-5)8602BAtomoxetine Actavis 40 mg (cps dur 28x40 mg (blis.PVC/PVDC/PVC/Al))30.8.2022R
 31.7.2022Teva Czech Industries s.r.o. (TEV-CZ-2)28902STOPANGIN (aer ora 1x30 ml (fľ.PVC))30.8.2022R
 14.7.2022Actavis Group PTC ehf. (ACT-5)35947Betahistin Actavis 16 mg (tbl 60x16 mg)30.8.2022R
 31.7.2022ratiopharm GmbH (RAT)51658Perindocombi 4 mg/1,25 mg (tbl 30x4 mg/1,25 mg (blis.PA/Al/PVC/Al))29.8.2022R

Predmet vo význame: R-Prerušenie, O-Obnovenie alebo Z-Zrušenie dodávok humánneho lieku


Účinnosť
Od
Do